Geneva, April 20 -- International Clinical Trials Registry received information related to the study (NCT07516769) titled 'Nicorandil as Anti-inflammatory in Rheumatoid Arthritis' on April 1.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Tanta University
Condition:
Rhumatoid Arthisis
Intervention:
Drug: Nicorandil 10 MG Oral Tablet
Recruitment Status: Not recruiting
Phase: Phase 3
Date of First Enrollment: April 2026
Target Sample Size: 46
Countries of Recruitment:
Egypt
To know more, visit https://clinicaltrials.gov/study/NCT07516769
Published by HT Digital Content Services with permissio...